J&J tops first-quarter profit estimates even as Stelara sales plunge (2026-04-14)
Strong demand for cancer drug Darzalex and psoriasis treatment Tremfya more ​than offset a steep falloff in ​sales of its blockbuster ​autoimmune drug Stelara.